Page last updated: 2024-08-25

rosiglitazone and Hypertension, Renovascular

rosiglitazone has been researched along with Hypertension, Renovascular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mandarim-de-Lacerda, CA; Mendonca, Lde S; Silva-Junior, Gde O; Torres, Tda S1

Other Studies

1 other study(ies) available for rosiglitazone and Hypertension, Renovascular

ArticleYear
Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2011, Volume: 63, Issue:1-2

    Topics: Animals; Aorta; Carotid Artery, Common; Hypertension, Renovascular; Immunohistochemistry; Insulin; Leptin; Male; Myocardium; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Tunica Intima

2011